Max Hodak
Chief Executive Officer
Max Hodak is the Founder and CEO of Science Corporation. Max founded the company in April of 2021 and leads its mission focused on restoring quality of life to those with debilitating conditions for which there are no treatment options, creating technology and devices aimed at restoring vision, cognition, and mobility.
Science’s PRIMA retina implant for patients blinded with late stage macular degeneration (loss of central visual field) has completed pivotal clinical trials with over eighty percent of patients achieving significant visual acuity improvements, making it the first BCI technology to restore functional vision to these patients. PRIMA received U.S. FDA Breakthrough status in 2023 and is currently in the process of gaining both FDA and European approval.
Science’s biohybrid BCI technology, which uses living neurons to connect to the brain instead of wires, circumvents the constraints of traditional neural interfaces and minimizes the damage done to the brain. Biohybrid technologies hold the potential to enable unprecedented new opportunities into restoring lost functionality due to brain injuries.
The Science BCI Ecosystem provides state-of-the-art components and vertically integrated infrastructure for companies and institutions to build upon, with the aim of simplifying the effort required to gather and analyze neural data, and to help bring neuro research into the modern era.
Prior to founding Science, Max was president of Neuralink, which he co-founded in 2016. He previously co-founded Transcriptic, a robotic cloud laboratory for the life sciences, where he was CEO.
Max began his life-long passion for BCI as a young child and started programming at the age of six. As a freshman at Duke University’s Pratt School of Engineering, studying biomedical engineering, he worked his way into the renowned Nicolelis Lab – one of the best neural engineering labs in the country, typically open only to graduate students – and spent his undergraduate years immersed in BCI research. Since graduating from Duke, his primary research and professional focus has been on neural engineering and the brain.
